Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2005

Main Data: 31/12 Year 2005
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 398.79
– gross margin 156.39
– total operating cost 117.33
– net operating profit 35.58
– financial expenses, net 7.54
– net income before taxes 12.46

 

Consolidated balance sheet Millions/Euro
– operating capital 77.40
– fixed assets, net 133.57
– reserves and MLT non financial payables -29.07
– net financial position -86.84
– stockholders’ equity 95.06

 

Other information Millions/Euro
– depreciation 13.61
– R & D expenses 18.27

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,686

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2005
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 156.5
– gross margin 58.9
– total operating cost 57.6
– net operating profit 1.3
– financial expenses, net 3.2
– net income before taxes -1.1

 

Consolidated balance sheet Millions/Euro
– operating capital 82.6
– fixed assets, net 132.0
– reserves and MLT non financial payables -30.5
– net financial position -101.8
– stockholders’ equity 82.3

 

Other information Millions/Euro
– depreciation 5.2
– R & D expenses 9.3

 

  No.
Employees 2,617

 

  Euro
Shares outstanding 18,772,000

 

Net sales by sector: Year 2005
  Millions/Euro  
tea, herbs & coffee 70.88 17.77%
pharmaceuticals packaging 223.43 56.03%
pharmaceuticals processing 104.48 26.20%
Total 398.79 100.00%

 

Net Sales by Country: Year 2005
  Millions/Euro  
E.U. (excluding Italy) 156.51 39.25%
Other European countries 31.38 7.87%
North America 86.25 21.63%
Asia & Middle East 50.28 12.61%
Other countries 35.77 8.97%
Total exports 360.19 90.32%
Italy 38.60 9.68%
Total 398.79 100.00%